Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10894089 Long-acting insulin or insulin analogue conjugate

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 17, 2016
Date of Patent
January 19, 2021
Patent Application Number
15551489
Patent Citations
‌
US Patent 10046061 Site-specific insulin conjugate
Patent Citations Received
‌
US Patent 11919935 Ultra-long acting insulin-Fc fusion proteins and methods of use
0
‌
US Patent 11352407 Ultra-long acting insulin-Fc fusion proteins
‌
US Patent 11359001 Insulin-Fc fusions and methods of use
‌
US Patent 11555058 Cells engineered to express ultra-long acting insulin-Fc fusion proteins
‌
US Patent 11261229 Ultra-long acting insulin-Fc fusion proteins and methods of use
‌
US Patent 11267862 Ultra-long acting insulin-Fc fusion proteins and methods of use
‌
US Patent 11667689 Insulin-Fc fusion proteins and methods of use to treat cancer
0
‌
US Patent 11673934 Ultra-long acting insulin-Fc fusion proteins and methods of use
0
‌
US Patent 11707517 Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use
0
‌
US Patent 11773151 Ultra-long acting insulin-Fc fusion proteins and methods of use
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10894089
Patent Primary Examiner
‌
Gyan Chandra

Find more entities like US Patent 10894089 Long-acting insulin or insulin analogue conjugate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo